Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Donald Hayden Insider Profile
4 Followers
Donald Hayden, Director at Insmed, holds 0.00 shares in Theseus Pharmaceuticals (Ticker: THRX), holds 0.00 shares in RegenXBio (Ticker: RGNX), holds 62.20K shares in Insmed (Ticker: INSM).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+19.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Donald Hayden holds in companies
Most Profitable Insider Trade
The most profitable trade made by Donald Hayden
Donald Hayden's Trading History
Insmed
Apr 11, 2019
Director
Uninformative Sell
207.38K
$1.59M
RegenXBio
Feb 12, 2020
Director
Uninformative Sell
1.24M
$0.00
Theseus Pharmaceuticals
Feb 14, 2024
―
Uninformative Sell
―
$0.00
Amicus
Jun 11, 2018
Director
Uninformative Buy
―
$92.77K
Vitae Pharma
Mar 21, 2016
―
Uninformative Sell
119.68K
$0.00
List of latest transactions for each holding click on a transaction to see Donald Hayden's performance on stock
You May Also Like
Donald Hayden insider profile FAQ
What is the percentage of profitable transactions made by Donald Hayden?
The percentage of profitable transactions made by Donald Hayden is 67%.
What is the average return per transaction made by Donald Hayden?
The average return per transaction made by Donald Hayden is 19.50%.
What stocks does Donald Hayden hold?
Donald Hayden holds: INSM, RGNX, THRX, FOLD, VTAE stocks.
What was Donald Hayden’s latest transaction?
Donald Hayden latest transaction was an Uninformative Sell of ―.
What was Donald Hayden's most profitable transaction?
Donald Hayden’s most profitable transaction was an Informative Sell of INSM stock on September 3, 2015. The return on the trade was 45.20%.
What is Donald Hayden's role in Insmed?
Donald Hayden's role in Insmed is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.